Q5127 – Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg

Long description

Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg

Short description

Inj, stimufend, 0.5 mg

Pricing indicator

51 Drugs

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

O1E Other drugs

ASC

Approved for ambulatory surgical centers

Added

April 1, 2023

Last change

April 1, 2023 – No change

Nearby Q codes

• Q5119 – Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg
• Q5120 – Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg
• Q5121 – Injection, infliximab-axxq, biosimilar, (avsola), 10 mg
• Q5122 – Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg
• Q5123 – Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
• Q5124 – Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg
• Q5125 – Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
• Q5126 – Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
• Q5128 – Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg
• Q5129 – Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg
• Q5130 – Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg
• Q5131 – Injection, adalimumab-aacf (idacio), biosimilar, 20 mg
• Q5132 – Injection, adalimumab-afzb (abrilada), biosimilar, 10 mg
• Q5133 – Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg
• Q5134 – Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg
• Q5135 – Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mg